Company / Tangible Book Value per Share
Bio-Rad Laboratories Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$235.33
FY2025
5-year range
$206.78 / $441.89
FY2021-FY2025
Trend
+13.8%
vs FY2024
Sector context
#2 of 158
Health Care
What the data says
Among 158 Health Care companies, Bio-Rad Laboratories is in the top 1% for tangible book value per share. Tangible Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $235.33.
Based on SEC 10-K filings.
235.33 in FY2025 with a 5-year CAGR of +13.6%. Ranks 2nd among 158 companies in Health Care.
Declined from $275.68 to $235.33 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -8.3%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- -
Sector benchmark
+1174.2% above sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 13.8% year-over-year.
- Ranks #2 out of 158 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $235.33 | +13.8% |
| FY2024 | $206.78 | -25.0% |
| FY2023 | $275.68 | -9.7% |
| FY2022 | $305.33 | -30.9% |
| FY2021 | $441.89 | +255.6% |
| FY2020 | $124.26 | -32.1% |
| FY2019 | $182.88 | +161.5% |
| FY2018 | $69.93 | +2.4% |
| FY2017 | $68.28 | +17.8% |
| FY2016 | $57.98 | -15.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026